WASHINGTON - The Senate Labor and Human Resources Committee unanimously approved a bipartisan compromise bill that sharply reduces restrictions on exports of FDA-regulated therapeutic products. At present, FDA requires that companies obtain a license prior to exporting any product that has not been approved for marketing in the U.S.

The compromise was proposed by Senators Judd Gregg, R-N.H., and Edward Kennedy, D-Mass., in response